Palatine Growth Credit provides INSTANDA with a growth credit facility
The London no-code insurance platform will use the capital for international expansion, hiring and further investment in AI and data science.
1 min read3 Aug 2026Founder & Editor
Alex Price is the founder & editor of Undiluted. Having previously built and sold an agency and media business to a debt financed roll up, he launched Undiluted in 2026. Alex talks with funds, banks, advisors and others across the growth lending ecosystem daily.
LinkedIn (opens in a new tab)The London no-code insurance platform will use the capital for international expansion, hiring and further investment in AI and data science.
1 min read3 Aug 2026The InvestEU-backed facility is split into three tranches and includes cash-settled synthetic warrants.
2 min read31 Jul 2026The London relocation software company will use the capital as working capital to expand funding and payment capacity for enterprise clients.
2 min read30 Jul 2026The loan will support research, development and clinical evaluation of an implantable neurostimulation device for chronic migraine and cluster headache. It is backed by InvestEU and sits under the EIB Group's TechEU programme.
2 min read29 Jul 2026Tickets will run from £5 million to £30 million for companies with at least £1.5 million of EBITDA. Two Arena Investors executives have been directors from day one.
1 min read28 Jul 2026The Spanish aerospace and defence company will use the loan as working capital on long-cycle industrial programmes. The facility came through Inveready Venture Finance IV Trainera.
1 min read16 Jul 2026The loan sits inside A$25 million of new funding that includes A$15 million of equity, and is the corporation's first venture debt deployment to a deep technology company.
2 min read8 Jul 2026Orbit Capital has reached a €107 million second close on Growth Debt Fund II, moving the Prague and Warsaw venture debt platform past its €100 million target.
2 min read2 Jul 2026Hercules Capital has provided 4D Molecular Therapeutics with a senior secured credit facility of up to $200 million. 4DMT drew $20 million at closing.
2 min read29 Jun 2026Hercules Capital has expanded its senior secured term loan facility with Dyne Therapeutics to $400 million. Dyne drew $50 million at this close. It has now borrowed $200 million, with $200 million still available.
2 min read17 Jun 2026